We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$233B
AUM Growth
-$27.8B
Cap. Flow
-$12.3B
Cap. Flow %
-5.26%
Top 10 Hldgs %
23.23%
Holding
2,904
New
60
Increased
1,374
Reduced
786
Closed
124

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$646M
2
ADP icon
Automatic Data Processing
ADP
+$510M
3
BIDU icon
Baidu
BIDU
+$349M
4
TSLA icon
Tesla
TSLA
+$320M
5
NVDA icon
NVIDIA
NVDA
+$261M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Healthcare 13.27%
3 Financials 12.05%
4 Consumer Discretionary 11.3%
5 Communication Services 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLBY icon
2651
Playboy Inc
PLBY
$136M
$163K ﹤0.01%
12,456
-9,541
-43% -$161K
DTIL icon
2652
Precision BioSciences
DTIL
$178M
$155K ﹤0.01%
1,678
HNST icon
2653
The Honest Company
HNST
$412M
$153K ﹤0.01%
29,400
PNT
2654
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$145K ﹤0.01%
18,200
GATO
2655
DELISTED
Gatos Silver, Inc.
GATO
$142K ﹤0.01%
32,800
FINV
2656
FinVolution Group
FINV
$1.17B
$141K ﹤0.01%
35,544
TRHC
2657
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$140K ﹤0.01%
24,377
ZYXI
2658
DELISTED
Zynex
ZYXI
$138K ﹤0.01%
22,220
RMO
2659
DELISTED
Romeo Power, Inc.
RMO
$138K ﹤0.01%
92,514
KNTE
2660
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$137K ﹤0.01%
+12,130
New +$134K
MILE
2661
DELISTED
Metromile, Inc. Common Stock
MILE
$134K ﹤0.01%
101,449
FMTX
2662
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$133K ﹤0.01%
14,300
SPRU icon
2663
Spruce Power Holding Corp
SPRU
$36.6M
$130K ﹤0.01%
8,191
AKBA icon
2664
Akebia Therapeutics
AKBA
$338M
$130K ﹤0.01%
180,790
LTCH
2665
DELISTED
Latch, Inc. Common Stock
LTCH
$128K ﹤0.01%
29,900
TLS icon
2666
Telos
TLS
$331M
$128K ﹤0.01%
12,805
CVM icon
2667
CEL-SCI Corp
CVM
$19.9M
$127K ﹤0.01%
1,081
DLTH icon
2668
Duluth Holdings
DLTH
$152M
$125K ﹤0.01%
10,232
ROOT icon
2669
Root
ROOT
$895M
$120K ﹤0.01%
3,394
LOTZ
2670
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$120K ﹤0.01%
87,695
DSEY
2671
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$120K ﹤0.01%
+15,794
New +$159K
AMBP icon
2672
Ardagh Metal Packaging
AMBP
$2.96B
$119K ﹤0.01%
14,606
DYN icon
2673
Dyne Therapeutics
DYN
$4.15B
$118K ﹤0.01%
12,222
AVIR icon
2674
Atea Pharmaceuticals
AVIR
$370M
$117K ﹤0.01%
16,149
TCRT icon
2675
Alaunos Therapeutics
TCRT
$4.64M
$115K ﹤0.01%
1,173

Similar funds

UBS AM's Q1 2022 Portfolio in Review

As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS AM opened a new position in Baidu worth $306M.

  • UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
  • UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
  • UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
  • UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
  • UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
  • UBS AM opened 60 new positions and closed 124 in Q1 2022.
  • UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.

Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.